HAVN Life Sciences Inc.
CNQ: HAVN.CN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Canadian Securities Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Tim Moore
- Headquarters
- Richmond, Canada
- IPO year
- 2020
- Market cap
- CA$1.2M
- Website
- https://www.havnlife.com
Loading HAVN…
Loading profile data…Frequently asked questions about HAVN
What does HAVN Life Sciences Inc. (HAVN.CN) do?
HAVN Life Sciences Inc., a biotechnology company, engages in the research and development of psychopharmacological products from plants and fungi. The Company also focuses on developing methodologies for the standardize and quality-controlled extraction of psychoactive compounds from plants and fungi, including Psilocybe spp. mushrooms; and the...
Where does HAVN.CN trade?
HAVN Life Sciences Inc. (HAVN.CN) trades on the Canadian Securities Exchange.
What sector is HAVN.CN in?
HAVN Life Sciences Inc. (HAVN.CN) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of HAVN Life Sciences Inc.?
Tim Moore is the chief executive officer of HAVN Life Sciences Inc. (HAVN.CN).
Where is HAVN Life Sciences Inc. headquartered?
HAVN Life Sciences Inc. is headquartered in Canada.
Does HAVN.CN pay a dividend?
HAVN Life Sciences Inc. (HAVN.CN) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did HAVN.CN go public?
HAVN Life Sciences Inc. (HAVN.CN) completed its initial public offering in 2020.